
("Ascent" or the "Company")
Interim results for the period ended
Highlights:
· Completion of shareholder distribution with ring-fenced access to 41% of the net proceeds received in relation to a positive outcome of the Company's significant Energy Charter Treaty ("ECT") damages claim.
· Conclusion of the hearing on merits and quantum in relation to the Company's significant ECT damages claim against the
· Expansion of the Company's footprint in
· Positive decision received in Ascent's favour relating to long standing dispute with Geoenergo D.o.o. (in administration) relating to amounts Ascent is owed from historic production but which Geoenergo refused to previously pay to Ascent.
· Board changes initiated, reprofiling of senior secured debt, implemented G&A cash cost reduction exercise and new funding secured.
Post Period End Highlights:
Arbitration Outcome:
· On
· Ascent Slovenia Limited was awarded
· Actual recovery of these funds depends on the finalisation of Geoenergo's administration process.
Leadership Changes:
· On
· On
Share Issuance on
· 215,274,654 new Ordinary shares (
· 89,552,239 shares to Locin Oil Corporation for a 49% interest in certain
· 111,940,299 shares to Arb Energy Utah, LLC for a 49% interest in certain
· 13,782,116 shares to C-suite and certain Directors, reflecting a 30% reduction in their cash compensation for six months, with settlement via equity on the same terms as the
· 6,891,058 new warrants were issued to C-suite and Directors in respect of these shares, as per the
Energy Charter Treaty (ECT) Claim Update:
· On
· No further substantive submissions are expected.
· The Tribunal's award on merits is expected towards the end of Q1 2026, with further updates to follow as necessary.
Enquiries
Jean-Michel Doublet |
|
Zeus, Nominated Adviser & Broker |
0203 829 5000 |
|
0207 399 9400
|
|
0203 411 7773 |
|
0207 186 9952 |
Chairman's Statement & Report
I am pleased and honoured to be addressing you for the first time as the new Chairman of your Company and to update you on progress through the first half of 2025 (the "Period" or "H1 2025"), which has seen significant evolution of
- Completion of shareholder distribution with ring-fenced access to 41% of the net proceeds received in relation to a positive outcome of the Company's significant Energy Charter Treaty ("ECT") damages claim;
- Conclusion of the hearing on merits and quantum in relation to the Company's significant ECT damages claim against the
- Expansion of the Company's footprint in
- Positive decision received in Ascent's favour relating to long standing dispute with Geoenergo D.o.o. (in administration) relating to amounts Ascent is owed from historic production but which Geoenergo refused to previously pay to Ascent; and
- Board changes initiated, reprofiling of senior secured debt, implemented G&A cash cost reduction exercise and new funding secured.
Shareholder Distribution
The first half of 2025 has seen the Company implement a shareholder distribution with rights to redeemable A2 Preference Shares which enfranchises the holder to receive their relevant pro rata portion of 41% of the net economic proceeds which may be realised in the Company's significant and well-advanced ECT damages claim against the
ECT Claim Progress
The ECT claim has continued to proceed in accordance with the timetable previously agreed at the opening of the arbitration proceedings. Notably during H1 2025, the Company and its lawyers attended the hearing on merits and quantum which was scheduled over five days in April this year and held in
Update on
Further to the Company's investment in
As a result of the indicated investment into and subsequent resumption of gas processing operations, Ascent and American Helium are positioned to resume production from their existing well bores which are already connected to the GNG gas gathering transmission system, and which were producing circa 3.2 mmscfpd gross to the JOA partners interests through H2 2024, prior to being shut-in alongside the GNG plant earlier this year. The resumption of gas processing activities by GNG and resumption of gas production from the American Helium operated leases in
Expansion of entry into
Consistent with the Company's prior move in 2024 into
- the acquisition of a 49% direct interest in over 100,000 acres of oil and gas leases in
- an initial acquisition of a 10% interest in 80,000 acres of leases owned and operated by
- changes to its Board including the decision by
These acquisitions are consistent with the Company's strategy to grow onshore
Accordingly, the Company entered into an agreement and joint operating agreement ("JOA") to acquire a 10% direct non-operated interest in oil and gas leases owned and operated by
The ARB portfolio has Proved Reserves (PDP plus PDNP) of 8.9 Bcf of natural gas net to the JOA partners (APN Energy Consultants LLC Appraisal of Reserves Report dated
ARB has tested the gas composition of many of the existing wells and identified up to 0.54% helium content in the producing gas streams. The leases have multiple potential upsides in up-dip and on-trend step-out prospects which ARB has estimated to have Proved Undeveloped Reserves of 44 Bcf, Probable Reserves of a further 23 Bcf and Prospective Resources of an additional 109 Bcf of natural gas with potentially 1.3 Bcf of helium included as well. At the time of signature of the transaction documents, the JOA partners agreed to jointly evaluate the prospect inventory with a view to high grading the opportunity set which is work that is currently on-going and expected to be finalised in the second half of 2025. In these evaluations the partners are evaluating targets in the Entrada formation which has a high helium content association of up-to 1% contained within the produceable natural gas and condensate volumes.
Shortly after announcing the transaction, towards the end of June, the Company and ARB initiated workover operations focusing on the
At the same time as the ARB acquisition described above, the Company also entered into an agreement and joint operating agreement ("JOA") to acquire a direct non-operated interest in 49% of the oil and gas leases owned and operated by
Locin's asset position in
Locin has tested the gas composition of several of the existing wells and has identified up-to 1.2% helium concentration in the producing gas streams. Also, Locin has identified several material prospects into target structures which have previously tested or produced gas in the 1960's and 70's as well as on-trend step-out prospects estimated by Locin to have gross Prospective Resources of an additional 663 Bcf of natural gas and potentially up to 5.3 Bcf of helium. Ascent and Locin have agreed to jointly evaluate the prospect inventory with a view to high grading the opportunity set over the coming months. In these evaluations, partners expect to target the Entrada producing formation which has a high associated helium content.
Slovenian Joint Venture Partner Insolvency & related disputes
Further to the Company's wholly owned subsidiary
Separately to the award above, ASL has also been invited by the insolvency court to enter mediation with the Administrator in relation to the Administrator's attempts to challenge the jurisdiction of the arbitration tribunal which was lodged around the time ASL requested to resume the arbitration proceedings. ASL believes the administrators position on this is also manifestly wrong, a view which was supported by the tribunal which included one Slovenian senior judge (former Supreme and
Board Changes & Cost Savings
Further to the Company's transformation over the last eighteen months, which include significant advancement of its Slovenian legacy claims and a successful repurposing of the Company to focus itself on growing onshore US oil and gas with helium assets, the Company proposed to appoint
During the period under review, Mr
During the period under review the Company also announced that as part of the refining of its board composition it no longer intended to immediately appoint a Chairman to the Board and accordingly the Company will now not be appointing Mr
Additionally, as part of positioning the Company to grow via a production-led strategy onshore
Corporate
In
The Company has further agreed with RiverFort to extend the remaining balance of the senior secured loan, being
The balance of new fundraising proceeds raised are being used to fund Ascent corporate costs and investment in the initial campaign to install artificial lift technologies on at least six existing wells included in the newly acquired ARB Energy acreage. Furthermore, the 9,480,000 million warrants issued to the
For the period to
Outlook
The Company is well positioned at the end of H1 2025 to be a
Jean-Michel Doublet
Non-Executive Chairman
Qualified Person's Statement
Consolidated Income Statement
for the Period ended
|
Notes |
Period ended £'000s |
Period ended £'000s |
|
|
|
|
Revenue |
2 |
78 |
1 |
Cost of sales |
|
(429) |
(26) |
Depreciation of oil & gas assets |
|
(1) |
(1) |
Gross (Loss)/Profit |
|
(352) |
(26) |
|
|
|
|
Other income |
|
12 |
- |
Administrative expenses |
|
(858) |
(786) |
Decommissioning provision |
|
(106) |
|
Impairment of prepaid abandonment fund |
|
- |
(240) |
(Loss)/Profit from operating activities |
|
(1,304) |
(1,052) |
|
|
|
|
Finance income |
|
45 |
- |
Finance cost |
|
(22) |
(23) |
Net finance costs |
|
23 |
(23) |
|
|
|
|
(Loss)/Profit before taxation |
|
(1,281) |
(1,075) |
|
|
|
|
Income tax expense |
|
- |
- |
(Loss)/Profit for the period after tax |
|
(1,281) |
(1,075) |
|
|
|
|
(Loss)/Profit) for the period attributable to equity shareholders |
|
(1,281) |
(1,075) |
|
|
|
|
Earnings per share |
|
|
|
Basic & fully diluted (loss)/profit per share (£) |
3 |
(0.34) |
(0.50) |
Consolidated Statement of Comprehensive Income
for the Period ended
|
Notes |
Period ended £'000s |
Period ended £'000s |
|
|
|
|
Profit / (loss) for the period |
|
(1,281) |
(1,075) |
|
|
|
|
Other comprehensive income |
|
|
|
|
|
|
|
Foreign currency translation differences for foreign operations |
|
(10) |
3 |
|
|
|
|
Total comprehensive gain / (loss) for the period |
|
(1,291) |
(1,072) |
Consolidated Statement of Financial Position
As at
|
Notes |
30 June 2025 £'000s |
31 December 2024 £'000s |
Assets |
|
|
|
Non-current assets |
|
|
|
Property, plant and equipment |
|
709 |
710 |
Other debtors |
4 |
662 |
677 |
Prepayments |
5 |
197 |
216 |
Total non-current assets |
|
1,568 |
1,603 |
Current assets |
|
|
|
Trade and other receivables |
5 |
187 |
415 |
Cash and cash equivalents |
|
458 |
111 |
Total current assets |
|
645 |
526 |
Total assets |
|
2,213 |
2,129 |
|
|
|
|
Equity and liabilities |
|
|
|
Attributable to the equity holders of the Parent Company |
|
|
|
Preference shares |
|
15 |
- |
Share capital |
8 |
10,430 |
8,989 |
Share premium account |
|
79,684 |
79,703 |
Merger reserve |
|
570 |
570 |
Share-based payment reserve |
9 |
644 |
726 |
Other equity reserves |
|
124 |
124 |
Translation reserves |
|
(244) |
(234) |
Retained earnings |
|
(91,522) |
(90,346) |
Total equity attributable to the shareholders |
|
(299) |
(468) |
|
|
|
|
Total equity |
|
(299) |
(468) |
|
|
|
|
Non-current liabilities |
|
|
|
Provisions |
|
1,050 |
1,019 |
Total non-current liabilities |
|
1,050 |
1,019 |
Current liabilities |
|
|
|
Convertible loan notes |
7 |
540 |
780 |
Derivative liability |
7 |
13 |
13 |
Trade and other payables |
6 |
909 |
785 |
Total current liabilities |
|
1,462 |
1,578 |
Total liabilities |
|
2,512 |
2,597 |
Total equity and liabilities |
|
2,213 |
2,129 |
Consolidated Statement of Changes in Equity
for the period ended
|
Share capital |
Share premium |
Merger reserve |
Share based payment reserve |
Other Reserves |
Translation reserve |
Retained earnings |
Total |
|
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
Balance at |
8,495 |
77,889 |
570 |
574 |
- |
(258) |
(87,648) |
(378) |
Comprehensive income |
|
|
|
|
|
|
|
|
Loss for the period |
- |
- |
- |
- |
- |
- |
(1,075) |
(1,075) |
Other comprehensive income |
|
|
|
|
|
|
|
|
Currency translation differences |
- |
- |
- |
- |
- |
3 |
- |
3 |
Total comprehensive income |
- |
- |
- |
- |
- |
3 |
(1,075) |
(1,072) |
Transactions with owners |
|
|
|
|
|
|
|
|
Issue of ordinary shares |
147 |
532 |
- |
- |
- |
- |
- |
679 |
Costs related to share issues |
- |
(23) |
- |
- |
- |
- |
- |
(23) |
Share-based payments - charge |
|
|
|
221 |
- |
|
|
221 |
Share-based payments - expired |
- |
- |
- |
(5) |
- |
- |
- |
(5) |
Total transactions with owners |
147 |
509 |
- |
216 |
- |
- |
- |
872 |
Balance at |
8,642 |
78,398 |
570 |
790 |
- |
(255) |
(88,723) |
(578) |
|
|
|
|
|
|
|
|
|
|
Share capital |
Share premium |
Merger reserve |
Share based payment reserve |
Other Reserves |
Translation reserve |
Retained earnings |
Total |
|
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
Balance at |
8,495 |
77,889 |
570 |
574 |
- |
(258) |
(87,648) |
(378) |
Comprehensive income |
|
|
|
|
|
|
|
|
Loss for the year |
- |
- |
- |
- |
- |
- |
(2,726) |
(2,726) |
Other comprehensive income |
|
|
|
|
|
|
|
|
Currency translation differences |
- |
- |
- |
- |
- |
24 |
- |
24 |
Total comprehensive income |
|
|
|
|
|
24 |
(2,726) |
(2,702) |
Transactions with owners |
|
|
|
|
|
|
|
|
Issue of ordinary shares |
494 |
1,856 |
- |
- |
- |
- |
- |
2,350 |
Costs related to share issues |
- |
(42) |
- |
- |
- |
- |
- |
(42) |
Equity component of convertible loan note |
- |
- |
- |
- |
124 |
- |
- |
124 |
Share-based payments - prior year correction |
- |
- |
- |
- |
- |
- |
23 |
23 |
Share-based payments - charge |
- |
- |
- |
157 |
- |
- |
- |
157 |
Share-based payments - expired |
- |
- |
- |
(5) |
- |
- |
5 |
- |
Total transactions with owners |
494 |
1,814 |
- |
152 |
124 |
- |
28 |
2,612 |
Balance at |
8,989 |
79,703 |
570 |
726 |
124 |
(234) |
(90,346) |
(468) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preference shares |
Share capital |
Share premium |
Merger reserve |
Share based payment reserve |
Other Reserves |
Translation reserve |
Retained earnings |
Total |
|
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
£'000s |
Balance at |
- |
8,989 |
79,703 |
570 |
726 |
124 |
(234) |
(90,346) |
(468) |
Comprehensive income |
|
|
|
|
|
|
|
|
|
Loss for the period |
- |
- |
- |
- |
- |
- |
- |
(1,281) |
(1,281) |
Other comprehensive income |
|
|
|
|
|
|
|
|
|
Currency translation differences |
- |
- |
- |
- |
- |
- |
(10) |
- |
(10) |
Total comprehensive income |
- |
- |
- |
- |
- |
- |
(10) |
(1,281) |
(1,291) |
Transactions with owners |
|
|
|
|
|
|
|
|
|
Issue of ordinary shares |
- |
1,441 |
43 |
- |
- |
- |
- |
- |
1,484 |
Costs related to share issues |
- |
- |
(47) |
- |
- |
- |
- |
- |
(47) |
Issue of preference shares |
15 |
- |
(15) |
- |
- |
- |
- |
- |
- |
Share-based payments - charge |
- |
- |
- |
- |
23 |
- |
- |
- |
23 |
Share-based payments - expired |
- |
- |
- |
- |
(105) |
- |
- |
105 |
- |
Total transactions with owners |
15 |
1,441 |
(19) |
- |
(82) |
- |
- |
105 |
1,460 |
Balance at |
15 |
10,430 |
79,684 |
570 |
644 |
124 |
(244) |
(91,522) |
(299) |
Consolidated Statement of Cash Flows
for the six months ended
|
Notes |
Period ended £'000s |
Period ended £'000s |
Cash flows from operations |
|
|
|
(loss)/Profit after tax for the period |
|
(1,281) |
(1,075) |
Depreciation |
|
1 |
1 |
Interest on loans |
|
(20) |
- |
Change in receivables |
|
(12) |
(68) |
Change in payables |
|
225 |
16 |
Change in provisions |
|
31 |
(113) |
Shares issued in exchange for services |
|
59 |
- |
Decrease of prepaid abandonment fund |
|
- |
262 |
Increase in share-based payments |
8 |
20 |
218 |
Exchange differences |
|
83 |
3 |
Net cash used in operating activities |
|
(894) |
(756) |
|
|
|
|
Cash flows from investing activities |
|
|
|
Cash paid for investment in American helium |
|
(198) |
- |
Loans repaid |
6 |
(221) |
- |
Investments in associates |
3 |
- |
(797) |
Net cash used in investing activities |
|
(419) |
(797) |
|
|
|
|
Cash flows from financing activities |
|
|
|
Interest paid and other finance fees |
|
- |
23 |
Proceeds from loans and borrowings |
|
- |
525 |
Proceeds from issue of shares |
7 |
1,707 |
678 |
Share issue costs |
|
(47) |
(23) |
Net cash generated from financing activities |
|
1,660 |
1,203 |
|
|
|
|
Net increase in cash and cash equivalents for the year |
|
347 |
(350) |
Effect of foreign exchange differences |
|
- |
- |
Cash and cash equivalents at beginning of the year |
|
111 |
475 |
Cash and cash equivalents at the end of the year |
|
458 |
125 |
Notes to the Interim Financial Statements
for the six months ended
1. Accounting Policies
Reporting entity
Basis of preparation
The interim financial statements have been prepared in accordance with
All amounts have been prepared in British pounds, this being the Group's presentational currency.
The interim financial information for the six months to
New Standards adopted as at
Accounting pronouncements which have become effective from
New accounting policies adopted for the interim period ended
Preference shares
The Company issued preference shares which have been classified as equity instruments, as they do not contain any contractual obligation to deliver cash or another financial asset and the payment of dividends is at the discretion of the Company. Dividends on these shares are recognised as a distribution to equity holders when they are declared. No liability is recognised for dividends until such time as they are approved by the Board of Directors.
Going Concern
The Financial Statements of the Group are prepared on a going concern basis.
On
Based on historical and recent support from new and existing investors the Board believes that such funding, if and when required, could be obtained through new debt or equity issuances. The Company is also seeking to monetise some of its large prospect inventory to farm-out new drilling opportunities and is already in advanced discussions with interested parties. However, there can be no guarantee over the outcome of these options and as a consequence there is a material uncertainty surrounding the Group's ability to raise the necessary finance, which may cast doubt on the Group's ability to operate as a going concern. Further, the Group may be unable to realise its assets and discharge its liabilities in the normal course of business.
Principal Risks and Uncertainties:
The principal risks and uncertainties affecting the business activities of the Group remain those detailed on pages 14-18 of the Annual Review 2024, a copy of which is available on the Company's website at www.ascentresources.co.uk.
2. Revenue
|
Period ended £'000s |
Period ended £'000s |
Revenue |
|
|
Oil sales |
39 |
- |
Gas sales |
39 |
- |
|
78 |
- |
During the period, the Company received revenues from its interest in American Helium Leases.
3. Earnings per share
|
Period ended £'000s |
Period ended £'000s |
Result for the period |
|
|
Total (loss)/Profit for the period attributable to equity shareholders |
(1,281) |
(1,075) |
|
|
|
Weighted average number of ordinary shares |
Number |
Number |
For basic earnings per share |
371,897,594 |
216,554,694 |
|
|
|
Earnings per share (£) |
(0.344) |
(0.497) |
4. Financial assets at fair value through profit and loss
|
£'000s |
At |
- |
Convertible loan notes receivable |
797 |
Adjustment to recognise at present value |
(194) |
Finance income |
71 |
Foreign exchange adjustment |
3 |
At |
677 |
|
|
At |
677 |
Finance income |
44 |
Foreign exchange adjustment |
(59) |
At |
662 |
On
- Date of maturity of
- The notes have a zero-coupon; and
- Converts, at the election of the Company, into 1 million membership units of GNG.
The convertible loan note is held at amortised cost. Management determined the present value to be
5. Trade & other receivables
|
£'000s |
£'000s |
Prepayments & accrued income |
384 |
274 |
Unpaid share capital |
- |
357 |
|
384 |
631 |
Less non-current portion |
(197) |
(216) |
Current portion |
187 |
415 |
6. Trade & other payables
|
£'000s |
£'000s |
Trade payables |
746 |
446 |
Tax and social security payable |
3 |
29 |
Accruals and deferred income |
160 |
112 |
Consideration due for the 49% |
- |
198 |
|
909 |
785 |
7. Borrowings
Group |
£'000s |
£'000s |
Current |
|
|
Convertible loan notes |
540 |
780 |
Derivative liability - conversion feature |
13 |
13 |
Non-current |
|
|
Borrowing |
- |
- |
|
553 |
793 |
Convertible loan notes
In
The Initial Loan has a 15% fixed coupon attached to it, payable on redemption, and warrants equal to 33% of the Initial Loan amount exercisable at 140% of the Issue Price at any time during the next four years. The Loan is secured against a company debenture.
The gross amount of the loan payable is
Under IFRS, the conversion feature of the loan has been bifurcated from the host debt liability and recognised initially at fair value and remeasured to fair value at the year end reporting date with the movements in fair value recognised in the profit and loss account. Transaction costs have been allocated proportionately between the host debt liability and the conversion feature, with the portion relating to the conversion feature being expensed immediately in profit and loss account. The portion relating to the host debt liability has been deducted against the carrying value of the host debt liability, and the portion relating to warrants deducted against equity. The host debt liability is accounted for under amortised cost using the appropriate discount rate which is deemed to be 20%. The warrants are measured at the residual amount of the transaction price less the fair value of the conversion feature and the present value of the host debt liability.
The fair value of the conversion feature was established using an appropriate model which resulted in a value of
On
The movement in the loans is analysed as follows:
Borrowings & CLN |
£'000s |
|
|
At |
780 |
Loan repayment |
(221) |
Conversion of loan to shares |
(75) |
Interest charged on principle |
23 |
Foreign exchange adjustment |
33 |
At |
540 |
Borrowings & CLN |
31 December 2024 £'000s |
|
|
At 1 January 2024 |
189 |
Loan repayment |
(91) |
Addition - Host debt liability |
709 |
Present value adjustment |
(192) |
Interest charged on principle |
203 |
Transaction costs of the Convertible loan note |
(53) |
Foreign exchange adjustment |
15 |
At 31 December 2024 |
780 |
8. Share capital
|
30 June 2025 £'000s |
31 December 2024 £'000s |
Authorised |
|
|
2,000,000,000 ordinary shares of 0.5p each |
10,000 |
10,000 |
|
|
|
Allotted, called up and fully paid |
|
|
3,019,648,452 deferred shares of 0.195p each |
5,888 |
5,888 |
1,737,110,763 deferred shares of 0.09p each |
1,563 |
1,563 |
165,567,280 ordinary shares of 0.5p each |
1,044 |
1,044 |
98,894,774 ordinary shares of 0.5p each |
494 |
494 |
1,149,058 ordinary shares of 0.5p each |
6 |
- |
270,000,000 ordinary shares of 0.5p each |
1,350 |
- |
10,300,465 ordinary shares of 0.5p each |
52 |
- |
6,660,000 ordinary shares of 0.5p each |
33 |
- |
Total |
10,430 |
8,989 |
|
|
|
Preference shares |
|
|
308,652,323 preference shares of 0.005p each |
15 |
- |
Total |
15 |
- |
|
|
|
Reconciliation of share capital movement |
Ordinary shares No. |
Ordinary shares No. |
Opening |
307,503,265 |
208,608,491 |
Issue of shares during the period |
288,109,523 |
98,894,774 |
Closing |
595,612,788 |
307,503,265 |
Shares issued during the period
Issuance of equity throughout the period:
· On 28 January 2025, 279,493 shares were issued to a former Director and 869,565 shares were issued to a supplier in relation to research services to be provided.
· On 22 May 2025, the Company raised total gross new equity proceeds of £1.35million from the issue of 270,000,000 new ordinary shares at a placings price of 0.5 pence per share.
· As per the new loan agreement with RiverFort Global Opportunities, US$100,000 of the outstanding loan was converted to 10,300,465 new ordinary shares on 22 May 2025.
· Also on 22 May 2025, 2,500,000 new ordinary shares of 0.5 pence each were issued to
· On 20 February 2025, 308,652,323 preference shares were issued at a price of 0.005p each.
9. Share based payments
The Company has provided the Directors, certain employees and institutional investors with share options and warrants ('options'). Options are exercisable at a price equal to the closing market price of the Company's shares on the date of grant. The exercisable period varies and can be up to seven years once fully vested after which time the option lapses.
Details of the share options outstanding during the year are as follows:
|
Shares |
Weighted Average price (pence) |
Outstanding at 1 January 2024 |
9,574,004 |
50.05 |
Granted during the year |
- |
- |
Outstanding at 31 December 2024 |
9,574,004 |
50.05 |
Exercisable at 31 December 2024 |
8,346,226 |
33.40 |
|
|
|
Outstanding at 1 January 2025 |
9,574,004 |
50.05 |
Granted during the period |
3,285,894 |
- |
Expired during the period |
4,881,057 |
- |
Outstanding at 30 June 2025 |
7,978,841 |
50.00 |
Exercisable at 30 June 2025 |
4,131,836 |
51.41 |
Options outstanding at 30 June 2025 have an exercise price of 5p (31 December 2024: 5p) and a weighted average contractual life of 7 years (31 December 2024: 1.4 years).
On 6 March 2024, the Company's wholly owned subsidiary, Ascent Claim Entitlement SPV Ltd, issued 6,171,788 options to Directors and certain employees. The options are exercisable at 0.005p for a period of 20 years after which time the option lapses.
Details of the share options issued by Ascent Claim Entitlement SPV Ltd and outstanding during the year are as follows:
|
Shares |
Weighted Average price (pence) |
Outstanding at 1 January 2024 |
- |
- |
Granted during the year |
6,171,788 |
- |
Outstanding at 31 December 2024 |
6,171,788 |
0.005 |
Exercisable at 31 December 2024 |
6,171,788 |
0.005 |
|
|
|
Outstanding at 1 January 2025 |
6,171,788 |
0.005 |
Outstanding at 30 June 2025 |
6,171,788 |
0.005 |
Exercisable at 30 June 2025 |
6,171,788 |
0.005 |
Details of total warrants outstanding at the end of the period are as follows:
|
Warrants |
Weighted Average price (pence) |
Outstanding at 1 January 2024 |
71,454,595 |
5.00 |
Granted during the period |
103,890,467 |
3.50 |
Exercised during the period |
- |
- |
Expired during the period |
- |
- |
Outstanding at 31 December 2024 |
175,345,062 |
4.80 |
Exercisable at 31 December 2024 |
175,345,062 |
4.80 |
|
|
|
Outstanding at 1 January 2025 |
175,345,062 |
4.80 |
Granted during the period |
- |
- |
Exercised during the period |
- |
- |
Expired during the period |
- |
- |
Outstanding at 30 June 2025 |
175,345,062 |
4.80 |
Exercisable at 30 June 2025 |
175,345,062 |
4.80 |
The warrants outstanding at the period end have a weighted average remaining contractual life of 1 year (31 December 2024: 1.5 years). The exercise prices of the warrants are between 2.30 - 7.50p per share (31 December 2024: 2.30 - 7.50p per share)
10. Events after the reporting period
On 3 July, the Company announced that the arbitration from December 2024 against its former Slovenian joint venture partner Geoenergo d.o.o. has concluded and has rendered in favour of the Company's 100% owned subsidiary Ascent Slovenia Limited. Ascent Slovenia Limited has been awarded €4,990,976 plus interest since 19 January 2024. Whilst Ascent Slovenia Limited is entitled to these amounts, the recovery of these payments is subject to the finalisation of the administration of Geoenergo and consequently Ascent Slovenia Limited may recover less than the full value of what it is owed.
On 9 July 2025, Mr
0n 15 July 2025, 215,274,654 new Ordinary shares, each of 0.5 pence nominal value were issued. 89,552,239 of the new shares were issued to Locin Oil Corporation, as consideration for a 49% share of their interest in certain oil and gas leases in
On 30 July 2025, Mr Jean-Michel Doublet was appointed Independent Non-Executive Chairman and Mr
On 23 September 2025, the Company announced in relation to the Company's ICSID registered Energy Charter Treaty claim against the
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.